Literature DB >> 9145792

Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats.

M T Akbar1, R Torp, N C Danbolt, L M Levy, B S Meldrum, O P Ottersen.   

Abstract

In situ hybridization techniques and quantitative western blotting were used to study the expression of the glial glutamate transporter GLT-1 and GLAST in the brains of normal (implanted, non-kindled) and fully kindled rats. Wistar rats were implanted with stimulating electrodes in the basolateral amygdala, and killed 28 days after the stimulated group had shown stage 5 seizures on five occasions. The brains were processed for in situ hybridization of messenger RNA for GLT-1 using 35S-labelled oligonucleotide probes or digoxigenin-labelled riboprobes. Paired (kindled and non-kindled) sections were used for qualitative and quantitative analyses. Image analysis of autoradiograms showed no change in expression of GLT-1 messenger RNA in any region of the hippocampus or in the cortex. An increase in expression of GLT-1 messenger RNA (expressed as percentage difference of control) was observed bilaterally in the striatum in kindled animals (16-21%, P<0.05). Nuclear emulsion-dipped sections showed predominant glial cell labelling in the hippocampus. Particle density analysis revealed reduced cell labelling in some kindled vs control pairs but overall there was no significant reduction in labelling in CA1. Equivalent results were found in CA1 using digoxigenin-labelled riboprobes. Quantitative immunoblotting also revealed no change in GLT-1 or GLAST transporter protein in the hippocampus of kindled animals. From these data we conclude that the enduring seizure susceptibility associated with the fully kindled state is unlikely to involve alterations in hippocampal GLT-1 messenger RNA or GLT-1 and GLAST transporter protein expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9145792     DOI: 10.1016/s0306-4522(96)00570-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  10 in total

Review 1.  Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.

Authors:  Nicola J Allen; Ragnhildur Káradóttir; David Attwell
Journal:  Pflugers Arch       Date:  2004-08-24       Impact factor: 3.657

Review 2.  Astrocytic regulation of glutamate homeostasis in epilepsy.

Authors:  Douglas A Coulter; Tore Eid
Journal:  Glia       Date:  2012-05-16       Impact factor: 7.452

3.  Increased expression of the neuronal glutamate transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy.

Authors:  Peter B Crino; Hong Jin; Melissa D Shumate; Michael B Robinson; Douglas A Coulter; Amy R Brooks-Kayal
Journal:  Epilepsia       Date:  2002-03       Impact factor: 5.864

4.  Ultrastructural and functional changes at the tripartite synapse during epileptogenesis in a model of temporal lobe epilepsy.

Authors:  Cheryl Clarkson; Roy M Smeal; Meredith G Hasenoehrl; John A White; Maria E Rubio; Karen S Wilcox
Journal:  Exp Neurol       Date:  2020-01-11       Impact factor: 5.330

5.  Effects of erythropoietin preconditioning on rat cerebral ischemia-reperfusion injury and the GLT-1/GLAST pathway.

Authors:  Daihua Yu; Yuanhua Fan; Xude Sun; Linong Yao; Wei Chai
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

Review 6.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

Review 7.  Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate.

Authors:  L J Willmore; Yuto Ueda
Journal:  Neurochem Res       Date:  2008-09-11       Impact factor: 3.996

Review 8.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

Review 9.  Novel astrocyte targets: new avenues for the therapeutic treatment of epilepsy.

Authors:  Vincenzo Crunelli; Giorgio Carmignoto; Christian Steinhäuser
Journal:  Neuroscientist       Date:  2014-03-07       Impact factor: 7.519

Review 10.  Glutamate as a neurotransmitter in the healthy brain.

Authors:  Y Zhou; N C Danbolt
Journal:  J Neural Transm (Vienna)       Date:  2014-03-01       Impact factor: 3.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.